Pathogens attributed to central-line-associated bloodstream infections in US acute-care hospitals during the first year of the coronavirus disease 2019 (COVID-19) pandemic

Lindsey M Weiner-Lastinger; Kathryn Haass; Cindy Gross; Denise Leaptrot; Emily Wong; Hsiu Wu; Margaret A Dudeck

doi:10.1017/ice.2022.16

Pathogens attributed to central-line-associated bloodstream infections in US acute-care hospitals during the first year of the coronavirus disease 2019 (COVID-19) pandemic

Infect Control Hosp Epidemiol. 2023 Apr;44(4):651-654. doi: 10.1017/ice.2022.16. Epub 2022 Feb 8.

Authors

Lindsey M Weiner-Lastinger¹, Kathryn Haass¹, Cindy Gross^{1

2}, Denise Leaptrot^{1

2}, Emily Wong^{1

3}, Hsiu Wu¹, Margaret A Dudeck¹

Affiliations

¹ Centers for Disease Control and Prevention, Atlanta, Georgia.
² CACI, Atlanta, Georgia.
³ Leidos, Atlanta, Georgia.

Abstract

To assess potential changes in the pathogens attributed to central-line-associated bloodstream infections between 2019 and 2020, hospital data from the National Healthcare Safety Network were analyzed. Compared to 2019, increases in the proportions of pathogens identified as Enterococcus faecalis and coagulase-negative staphylococci were observed during 2020.

MeSH terms

COVID-19*
Cross Infection* / epidemiology
Hospitals
Humans
Pandemics
Sepsis*